Table II.
Groups | |||||
---|---|---|---|---|---|
Items | Typical (n=52) | Atypical (n=13) | Control (n=62) | t/χ2 value | P-value |
FBG (mmol/l) | 5.21±0.34 | 5.15±0.33 | 5.13±0.35 | 0.485 | 0.641 |
HbA1c (%) | 5.87±0.56 | 5.68±0.51 | 5.64±0.49 | 0.865 | 0.073 |
FINS (pmmol/l) | 18.45±5.32 | 10.23±3.47a | 10.18±3.21a | 7.967 | 0.003 |
HOMA-IR | 3.93±1.19 | 2.36±1.06a | 2.29±1.02a | 3.932 | 0.008 |
FSH (mIU/ml) | 37.84±9.65 | 36.47±9.65 | 50.21±9.76a,b | 8.215 | 0.002 |
LH (mIU/ml) | 29.12±10.07 | 29.65±10.28 | 30.13±10.62 | 0.634 | 0.516 |
E2 (pg/ml) | 472.32±56.25 | 462.32±55.76 | 367.61±55.43a,b | 4.864 | 0.006 |
Compared with typical group, P<0.05
compared with atypical group, P<0.05; FBG, fasting blood glucose glucose; HbA1c, glycosylated hemoglobin; FINS, fasting insulin level; HOMA-IR, insulin resistance index; FSH, follicle estrogen; LH, luteinizing hormone; SD, standard deviation.